UPDATED: Not 3 weeks after taking Humacyte public, Rajiv Shukla launches another blank check company
One of biotech’s earliest SPAC investors is back with another blank check company, less than a month after his last effort announced its intent to merge.
Rajiv Shukla is intending to take a third lucky winner public with Alpha Healthcare Acquisition III, filing to go public Thursday with a $150 million raise penciled in. The move comes just a couple of weeks after Shukla’s second SPAC said it would jump to Nasdaq in tandem with Laura Niklason’s Humacyte in a $255 million new investment.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 106,500+ biopharma pros reading Endpoints daily — and it's free.